Rosiglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, Restores Alveolar and Pulmonary Vascular Development in a Rat Model of Bronchopulmonary Dysplasia

논문상세정보
' Rosiglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, Restores Alveolar and Pulmonary Vascular Development in a Rat Model of Bronchopulmonary Dysplasia' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • alveolarization
  • bronchopulmonary dysplasia
  • peroxisomeproliferator-activatedreceptor-γ
  • rosiglitazone
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,590 0

0.0%

' Rosiglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, Restores Alveolar and Pulmonary Vascular Development in a Rat Model of Bronchopulmonary Dysplasia' 의 참고문헌

  • Ventricular weight in cardiac hypertrophy
    Fulton RM Br Heart J 14 : 413 ~ 420 [1952]
  • Ventricular weight in cardiac hypertrophy
    Fulton RM Br Heart J 14 413-420 [1952]
  • Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization
    Thébaud B Circulation 112 : 2477 ~ 2486 [2005]
  • Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization
    Thébaud B Circulation 112 2477-2486 [2005]
  • The role of fibroblast transdifferentiation in lung epithelial cell proliferation, differentiation, and repair in vitro
    Torday JS Pediatr Pathol Mol Med 22 : 189 ~ 207 [2003]
  • The role of fibroblast transdifferentiation in lung epithelial cell proliferation, differentiation, and repair in vitro
    Torday JS Pediatr Pathol Mol Med 22 189-207 [2003]
  • The pulmonary lipofibroblast (lipid interstitial cell) and its contributions to alveolar development
    McGowan SE Annu Rev Physiol 59 : 43 ~ 62 [1997]
  • The pulmonary lipofibroblast (lipid interstitial cell) and its contributions to alveolar development
    McGowan SE Annu Rev Physiol 59 43-62 [1997]
  • The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation
    Ricote M Nature 391 : 79 ~ 82 [1998]
  • The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation
    Ricote, M. Nature 391 79-82 [1998]
  • The evolutionary continuum from lung development to homeostasis and repair
    Torday JS Am J Physiol Lung Cell Mol Physiol 292 : L608 ~ L611 [2007]
  • The evolutionary continuum from lung development to homeostasis and repair
    Torday JS Am J Physiol Lung Cell Mol Physiol 292 L608-L611 [2007]
  • Stretch-stimulated surfactant synthesis is coordinated by the paracrine actions of PTHrP and leptin
    Torday JS Am J Physiol Lung Cell Mol Physiol 283 : L130 ~ L135 [2002]
  • Stretch-stimulated surfactant synthesis is coordinated by the paracrine actions of PTHrP and leptin
    Torday JS Am J Physiol Lung Cell Mol Physiol 283 L130-L135 [2002]
  • Sildenafil Alleviates Bronchopulmonary Dysplasia in Neonatal Rats by Activating the Hypoxia-Inducible Factor Signaling Pathway
    Park HS AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY 48 (1) : 105 ~ 113 [2013]
  • Sildenafil Alleviates Bronchopulmonary Dysplasia in Neonatal Rats by Activating the Hypoxia-Inducible Factor Signaling Pathway
    Park HS AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY 48 1 105-113 [2013]
  • Serial changes of lung morphology and biochemical profiles in a rat model of bronchopulmonary dysplasia induced by intra-amniotic lipopolysaccharide and postnatal hyperoxia
    Lee HJ JOURNAL OF PERINATAL MEDICINE 38 (6) : 675 ~ 681 [2010]
  • Serial changes of lung morphology and biochemical profiles in a rat model of bronchopulmonary dysplasia induced by intra-amniotic lipopolysaccharide and postnatal hyperoxia
    Lee HJ JOURNAL OF PERINATAL MEDICINE 38 6 675-681 [2010]
  • Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, prevents hyperoxia-induced neonatal rat lung injury in vivo
    Rehan VK Pediatr Pulmonol 41 : 558 ~ 569 [2006]
  • Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, prevents hyperoxia-induced neonatal rat lung injury in vivo
    Rehan VK Pediatr Pulmonol 41 558-569 [2006]
  • Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation
    Cuzzocrea S Eur J Pharmacol 483 : 79 ~ 93 [2004]
  • Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation
    Cuzzocrea S Eur J Pharmacol 483 79-93 [2004]
  • Recombinant human VEGF treatment transiently increases lung edema but enhances lung structure after neonatal hyperoxia
    Kunig AM Am J Physiol Lung Cell Mol Physiol 291 : L1068 ~ L1078 [2006]
  • Recombinant human VEGF treatment transiently increases lung edema but enhances lung structure after neonatal hyperoxia
    Kunig AM Am J Physiol Lung Cell Mol Physiol 291 L1068-L1078 [2006]
  • Peroxisome proliferator-activated receptors: insight into multiple cellular functions
    Escher, P. Mutat Res 448 : 121 ~ 138 [2000]
  • Peroxisome proliferator-activated receptors: insight into multiple cellular functions
    Escher, P. Mutat Res 448 121-138 [2000]
  • Peroxisome proliferator-activated receptors and angiogenesis
    Biscetti F Nutr Metab Cardiovasc Dis 19 : 751 ~ 759 [2009]
  • Peroxisome proliferator-activated receptors and angiogenesis
    Biscetti F Nutr Metab Cardiovasc Dis 19 751-759 [2009]
  • Peroxisome proliferator-activated receptor-gamma agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells
    Yamakawa K Biochem Biophys Res Commun 271 : 571 ~ 574 [2000]
  • Peroxisome proliferator-activated receptor-gamma agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells
    Yamakawa K Biochem Biophys Res Commun 271 571-574 [2000]
  • Peroxisome proliferator-activated receptor gamma agonists enhance lung maturation in a neonatal rat model
    Wang Y Pediatr Res 65 : 150 ~ 155 [2009]
  • Peroxisome proliferator-activated receptor gamma agonists enhance lung maturation in a neonatal rat model
    Wang Y Pediatr Res 65 150-155 [2009]
  • PPARγ Signaling Mediates the Evolution, Development, Homeostasis, and Repair of the Lung
    Rehan VK PPAR Res 2012 : 289867 ~ [2012]
  • PPARγ Signaling Mediates the Evolution, Development, Homeostasis, and Repair of the Lung
    Rehan VK PPAR Res 2012 289867- [2012]
  • Oxygen and oxidative stress in bronchopulmonary dysplasia
    Saugstad OD J Perinat Med 38 : 571 ~ 577 [2010]
  • Oxygen and oxidative stress in bronchopulmonary dysplasia
    Saugstad OD J Perinat Med 38 571-577 [2010]
  • Medical significance of peroxisome proliferator-activated receptors
    Vamecq J Lancet 354 : 141 ~ 148 [1999]
  • Medical significance of peroxisome proliferator-activated receptors
    Vamecq J Lancet 354 141-148 [1999]
  • Mechanism of reduced lung injury by high-frequency nasal ventilation in a preterm lamb model of neonatal chronic lung disease
    Rehan VK Pediatr Res 70 : 462 ~ 466 [2011]
  • Mechanism of reduced lung injury by high-frequency nasal ventilation in a preterm lamb model of neonatal chronic lung disease
    Rehan VK Pediatr Res 70 462-466 [2011]
  • Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia
    Stenmark KR Annu Rev Physiol 67 : 623 ~ 661 [2005]
  • Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia
    Stenmark KR Annu Rev Physiol 67 623-661 [2005]
  • Inflammation and bronchopulmonary dysplasia: a continuing story
    Speer CP Semin Fetal Neonatal Med 11 : 354 ~ 362 [2006]
  • Inflammation and bronchopulmonary dysplasia: a continuing story
    Speer CP Semin Fetal Neonatal Med 11 354-362 [2006]
  • Hyperoxia-induced neonatal rat lung injury involves activation of TGF-{beta} and Wnt signaling and is protected by rosiglitazone
    Dasgupta C Am J Physiol Lung Cell Mol Physiol 296 : L1031 ~ L1041 [2009]
  • Hyperoxia-induced neonatal rat lung injury involves activation of TGF-{beta} and Wnt signaling and is protected by rosiglitazone
    Dasgupta C Am J Physiol Lung Cell Mol Physiol 296 L1031-L1041 [2009]
  • Effects of hyperoxia on VEGF, its receptors, and HIF-2alpha in the newborn rat lung
    Hosford GE Am J Physiol Lung Cell Mol Physiol 285 : L161 ~ L168 [2003]
  • Effects of hyperoxia on VEGF, its receptors, and HIF-2alpha in the newborn rat lung
    Hosford GE Am J Physiol Lung Cell Mol Physiol 285 L161-L168 [2003]
  • Effects of Postnatal Dexamethasone or Hydrocortisone in a Rat Model of Antenatal Lipopolysaccharide and Neonatal Hyperoxia Exposure
    이현주 Journal of Korean Medical Science 27 (4) : 395 ~ 401 [2012]
  • Effects of Postnatal Dexamethasone or Hydrocortisone in a Rat Model of Antenatal Lipopolysaccharide and Neonatal Hyperoxia Exposure
    이현주 Journal of Korean Medical Science 27 4 395-401 [2012]
  • Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia
    Bhatt AJ Am J Respir Crit Care Med 164 (10 Pt 1) : 1971 ~ 1980 [2001]
  • Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia
    Bhatt AJ Am J Respir Crit Care Med 164 10 Pt 1 1971-1980 [2001]
  • Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review and meta-analysis
    Hartling L Arch Dis Child Fetal Neonatal Ed 97 : F8 ~ F17 [2012]
  • Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review and meta-analysis
    Hartling L Arch Dis Child Fetal Neonatal Ed 97 F8-F17 [2012]
  • Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators
    Corton JC Annu Rev Pharmacol Toxicol 40 : 491 ~ 518 [2000]
  • Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators
    Corton JC Annu Rev Pharmacol Toxicol 40 491-518 [2000]
  • Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease
    Thébaud B Am J Respir Crit Care Med 175 : 978 ~ 985 [2007]
  • Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease
    Thébaud B Am J Respir Crit Care Med 175 978-985 [2007]
  • Bronchopulmonary dysplasia: then and now
    Philip AG Neonatology 102 : 1 ~ 8 [2012]
  • Bronchopulmonary dysplasia: then and now
    Philip AG Neonatology 102 1-8 [2012]
  • Bronchopulmonary dysplasia in a rat model induced by intra-amniotic inflammation and postnatal hyperoxia: Morphometric aspects
    Choi CW Pediatric Research 65 (3) : 323 ~ 327 [2009]
  • Bronchopulmonary dysplasia in a rat model induced by intra-amniotic inflammation and postnatal hyperoxia: Morphometric aspects
    Choi CW Pediatric Research 65 3 323-327 [2009]
  • Association of Increased Pulmonary Interleukin-6 with the Priming Effect of Intra-Amniotic Lipopolysaccharide on Hyperoxic Lung Injury in a Rat Model of Bronchopulmonary Dysplasia
    Kim DH NEONATOLOGY 98 (1) : 23 ~ 32 [2010]
  • Association of Increased Pulmonary Interleukin-6 with the Priming Effect of Intra-Amniotic Lipopolysaccharide on Hyperoxic Lung Injury in a Rat Model of Bronchopulmonary Dysplasia
    Kim DH NEONATOLOGY 98 1 23-32 [2010]
  • Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons
    Maniscalco WM Am J Physiol Lung Cell Mol Physiol 282 : L811 ~ L823 [2002]
  • Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons
    Maniscalco WM Am J Physiol Lung Cell Mol Physiol 282 L811-L823 [2002]
  • A paradoxical temporal response of the PTHrP/PPARgamma signaling pathway to lipopolysaccharide in an in vitro model of the developing rat lung
    Rehan VK Am J Physiol Lung Cell Mol Physiol 293 : L182 ~ L190 [2007]
  • A paradoxical temporal response of the PTHrP/PPARgamma signaling pathway to lipopolysaccharide in an in vitro model of the developing rat lung
    Rehan VK Am J Physiol Lung Cell Mol Physiol 293 L182-L190 [2007]